LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 2.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $18,275,000 | +11.1% | 133,460 | +10.5% | 0.38% | +7.0% |
| Q3 2017 | $16,450,000 | -0.8% | 120,820 | -11.6% | 0.36% | +1.1% |
| Q2 2017 | $16,586,000 | +26.4% | 136,620 | +10.2% | 0.35% | +24.4% |
| Q1 2017 | $13,123,000 | +59.3% | 123,985 | +53.0% | 0.28% | +52.2% |
| Q4 2016 | $8,236,000 | +21.7% | 81,055 | +22.3% | 0.19% | +44.2% |
| Q3 2016 | $6,765,000 | -14.4% | 66,285 | 0.0% | 0.13% | -17.8% |
| Q2 2016 | $7,906,000 | +17.1% | 66,285 | +5.1% | 0.16% | +17.2% |
| Q1 2016 | $6,753,000 | -1.4% | 63,055 | -0.2% | 0.13% | +2.3% |
| Q4 2015 | $6,851,000 | +31.4% | 63,190 | +3.8% | 0.13% | +23.6% |
| Q3 2015 | $5,215,000 | -5.5% | 60,890 | +11.4% | 0.11% | +7.1% |
| Q2 2015 | $5,516,000 | – | 54,670 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |